2011 studies found for:    Open Studies | "Hematologic Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hematologic Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Integrated Whole-Genome Analysis of Hematologic Disorders
Condition: Hematologic Diseases
Interventions: Procedure: Blood Draw;   Procedure: Skin Biopsy
2 Not yet recruiting The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study
Condition: Hematologic Diseases
Intervention: Other: Touch-massage
3 Recruiting Evaluation of Patients With Blood Disorders
Condition: Hematologic Disease
Intervention:
4 Recruiting Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
Conditions: Hematologic Disease;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndrome;   Myeloproliferative Disorder
Intervention: Procedure: Stem cell transplantation
5 Recruiting Evaluation, Treatment, and Training for Patients With Blood Disorders
Conditions: Hematologic Disease;   Hematologic Neoplasm;   Pancytopenia
Intervention:
6 Recruiting Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery
Conditions: Blood and Blood Disorders;   Anemia, Neonatal;   Hematologic Disease;   Infant, Newborn, Diseases
Intervention: Procedure: Fetoscopic laser surgery
7 Unknown  Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Condition: Febrile Neutropenia
Interventions: Drug: ciprofloxacin;   Drug: cefepime
8 Recruiting Stem Cell Transplant for Patients With Sickle Cell Disease (SCD), Thalassemia, Diamond Blackfan Anemia (DBA) and Other Non-malignant (Non-cancerous) Hematologic Disorders
Conditions: Sickle Cell Disease;   Thalassemia;   Diamond Blackfan Anemia;   Non-malignant Hematologic Disorders
Interventions: Drug: Anti-thymocyte globulin (ATG);   Drug: Fludarabine monophosphate;   Drug: Busulfan;   Drug: Alemtuzumab;   Drug: Cyclophosphamide;   Drug: Mesna;   Radiation: total body irradiation
9 Unknown  Registry of Febrile Neutropenia and Invasive Fungal Infections
Conditions: Hematological Disease;   Febrile Neutropenia;   Fungal Infections
Intervention: Other: Patient registry
10 Unknown  ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding
Condition: Hematologic Diseases
Intervention: Drug: Bivalirudin
11 Recruiting A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Conditions: Primary Myelofibrosis;   Thrombocythemia, Essential;   Thrombocytosis;   Myeloproliferative Disorders;   Bone Marrow Diseases;   Hematologic Diseases;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hemorrhagic Disorders
Interventions: Drug: LDE225;   Drug: INC424
12 Recruiting Bone Marrow Grafting for Leukemia and Lymphoma
Conditions: Leukemia;   Lymphoma;   Hematologic Diseases
Intervention: Procedure: collection and storage of tissue samples for research
13 Recruiting Transplants With Unlicensed Preserved Cord Blood
Conditions: Myelodysplastic Syndrome (MDS);   Hematologic Neoplasms;   Hematologic Diseases;   Severe Aplastic Anemia
Intervention: Procedure: Cord Blood Transplant
14 Unknown  Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation
Condition: Hematologic Diseases
Intervention: Drug: Everolimus and mycophenolate sodium
15 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:
16 Recruiting Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells
Condition: Hematologic Diseases
Intervention:
17 Recruiting Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.
Conditions: Leukemia;   Leukemia,Pediatric;   Leukemia, Myleiod;   Leukemia, Mylegenous, Chronic;   Leukemia, Mylegenous, Accelerated;   BCR-ABL Positive;   Myeloproliferative Disorder;   Bone Marrow Disease;   Hematologic Diseases;   Neoplastic Processes;   Imatinib;   Dasatinib;   Enzyme Inhibitor;   Protein Kinase Inhibitor
Intervention: Drug: nilotinib
18 Unknown  Intra Bone Marrow Injection Of Unrelated Cord Blood Cells
Condition: Hematologic Diseases
Intervention: Procedure: Intrabone Marrow Injection
19 Unknown  A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
Conditions: Anemia;   Intestinal Helminthiasis;   Intestinal Schistosomiasis;   Human Immunodeficiency Virus I Infection;   Hematologic Diseases;   Opportunistic Infections
Intervention: Drug: Praziquantel and Albendazole
20 Not yet recruiting Registry of Philadelphia-Negative Myeloproliferative Neoplasms
Condition: Hematologic Diseases
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years